...
首页> 外文期刊>Eastern Journal of Medicine >Evaluation of hematologic and biochemical parameters in patients with early stage uterine malignancy receiving radiotherapy
【24h】

Evaluation of hematologic and biochemical parameters in patients with early stage uterine malignancy receiving radiotherapy

机译:放疗对早期子宫恶性肿瘤患者血液学和生化指标的评价

获取原文
           

摘要

Evaluation of hematologic and biochemical parameters in patients with early stage uterine malignancy receiving radiotherapy Feryal Karaca 1, Selahattin Mente?1, S?dd?k Keskin2 1Adana ?ehir Hastanesi Sa?l?k Bilimleri üniversitesi Radyasyon Onkolojisi 2Yüzüncü Y?l üniversitesi T?p Fakültesi Biyoistatistik Anabilim Dal? INTRODUCTION: Surgery is the primary choice of treatment fort this disorder. Radiotherapy is an important step of treatment in this cancer after surgery due to the stage of the disease. Lack of prospective randomised data for survival limits the use of adjuvant radiotherapy. Hovewer Adjuvant radiotherapy is suggested for high risk patients to reduce locoregional recurrence. The aim of this study is to define the statistical difference of hemogram, transaminases, kidney function tests and electrolyte changes in patients before starting radiotherapy, the end of radiotherapy, with the onset of acute side effects, and three months after finishing radiotherapy with the onset of chronic side effects. METHODS: .18 patients with early stage endometrial malignancy attending to Adana Numune Training and Research Hospital have been included. This study has assessed the changes in hemogram, blood transaminases, ürea, creatinin and electrolyte values of patients before radiotherapy, at the last week of radiotherapy and three months after radiotherapy have been compared. RESULTS: The values for were statistically significant for AST, Ca, LDH, urea, Hb ve HTC values before treatment, at the end of the treatment and three months after treatment (p0.05). DISCUSSION AND CONCLUSION: The effect of radiotheraphy seen as lower values of hemoglobin and hematocrite in endometrial malignancy patients resolved and become normal after three months of the radiotherapy.
机译:接受放疗的早期子宫恶性肿瘤患者血液学和生化指标的评估Feryal Karaca 1,Selahattin Mente?1,S?dd?k Keskin2 1Adana?ehir Hastanesi Sa?l?k BilimleriüniversitesiRadyasyon Onkolojisi2YüzüncüY?lüniversite pFakültesiBiyoistatistik Anabilim Dal?引言:手术是治疗这种疾病的主要选择。由于该疾病的分期,放疗是该癌症手术后治疗的重要步骤。缺乏生存前瞻性随机数据限制了辅助放疗的使用。对于高危患者,建议使用Hovewer辅助放疗以减少局部复发。这项研究的目的是确定开始放疗前,放疗结束,急性副作用发作以及放疗结束后三个月患者的血栓图,转氨酶,肾功能检查和电解质变化的统计学差异。慢性副作用。方法:.18名在Adana Numune培训和研究医院就诊的早期子宫内膜恶性肿瘤患者被纳入研究。这项研究评估了放疗前,放疗的最后一周和放疗后三个月的患者血脂,转氨酶,尿素,肌酐和电解质值的变化。结果:治疗前,治疗结束时和治疗后三个月的AST,Ca,LDH,尿素,Hb ve HTC值具有统计学意义(p <0.05)。讨论与结论:子宫内膜恶性肿瘤患者的血红蛋白和血红蛋白值降低,放射治疗的效果得以缓解,并在放疗三个月后恢复正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号